January 2026
1. BRAUTIGAM K, Baker AM, Koelzer VH, Kather JN, et al
   Integrating artificial intelligence (AI) into colorectal cancer reporting.
   J Pathol. 2026 Jan 26. doi: 10.1002/path.70029.
   

   >> Share

   
   
2. KOBA T, Hibiya T, Shibayama T, Kato K, et al
   Relative MYC downregulation and RUNX2 upregulation orchestrate partial epithelial-mesenchymal transition in colorectal cancer tumor budding and poorly differentiated clusters.
   J Pathol. 2026 Jan 9. doi: 10.1002/path.70013.
   

   >> Share

   
   November 2025
3. CHAN-PAK-CHOON F, Beaumont C, Camacho Valenzuela J, Leblanc J, et al
   APC-related multiple salivary gland lesions: spatial transcriptomic analysis reveals progressive WNT activation.
   J Pathol. 2025;267:241-248.
   

   >> Share

   
   June 2025
4. WARD JC, Morgan M, Wood J, Woolley C, et al
   Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.
   J Pathol. 2025 Jun 22. doi: 10.1002/path.6446.
   

   >> Share

   
   May 2025
5. GREEN EH, Kotrannavar SR, Rutherford ME, Lunnemann HM, et al
   Multiomic spatial atlas shows deleted in malignant brain tumors 1 (DMBT1) glycoprotein is lost in colonic dysplasia.
   J Pathol. 2025;266:51-65.
   

   >> Share

   
   April 2025
6. CLARKSON E, Lewis A
   BMP signalling in colorectal cancer: losing the yin to WNTs yang.
   J Pathol. 2025 Apr 11. doi: 10.1002/path.6428.
   

   >> Share

   
   
7. HUANG Z, Mandelkow T, Debatin NF, Lurati MCJ, et al
   A Tc1- and Th1-T-lymphocyte-rich tumor microenvironment is a hallmark of MSI colorectal cancer.
   J Pathol. 2025 Apr 3. doi: 10.1002/path.6415.
   

   >> Share

   
   
8. AIJALA VK, Harkonen J, Mantere T, Elomaa H, et al
   Comprehensive characterization of micropapillary colorectal adenocarcinoma.
   J Pathol. 2025;265:408-421.
   

   >> Share

   
   March 2025
9. MATSUURA Y, Onuma K, Coppo R, Uematsu H, et al
   Dynamic change of polarity in spread through air spaces of pulmonary malignancies.
   J Pathol. 2025;265:260-273.
   

   >> Share

   
   February 2025
10. TRAHEARN N, Sakr C, Banerjee A, Lee SH, et al
    Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome.
    J Pathol. 2025;265:198-210.
    

    >> Share

    
    January 2025
11. LABORDE N, Barusseaud A, Quaranta M, Rolland C, et al
    Human colonic organoids for understanding early events of familial adenomatous polyposis pathogenesis.
    J Pathol. 2025;265:26-40.
    

    >> Share

    
    December 2024
12. SCHOENPFLUG LA, Chatzipli A, Sirinukunwattana K, Richman S, et al
    Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.
    J Pathol. 2024 Dec 22. doi: 10.1002/path.6376.
    

    >> Share

    
    November 2024
13. YONG Y, Demmler R, Zohud BA, Fang Q, et al
    AMIGO2 characterizes cancer-associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes.
    J Pathol. 2024 Nov 11. doi: 10.1002/path.6363.
    

    >> Share

    
    October 2024
14. AZIMI M, Cho S, Bozkurt E, McDonough E, et al
    Spatial effects of infiltrating T cells on neighbouring cancer cells and prognosis in stage III CRC patients.
    J Pathol. 2024;264:148-159.
    

    >> Share

    
    July 2024
15. GEURTS BS, Zeverijn LJ, van Berge Henegouwen JM, van der Wijngaart H, et al
    Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.
    J Pathol. 2024;263:288-299.
    

    >> Share

    
    
16. PASTOR-MORATE D, Amigo-Moran L, Garranzo-Asensio M, Rejas-Gonzalez R, et al
    DeltaNp73 and its effector targets promote colorectal peritoneal carcinosis and predict survival.
    J Pathol. 2024;263:328-337.
    

    >> Share

    
    May 2024
17. MAKINO K, Ishii T, Takeda H, Saito Y, et al
    Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency.
    J Pathol. 2024;263:32-46.
    

    >> Share

    
    March 2024
18. DE KLAVER W, de Wit M, Bolijn A, Tijssen M, et al
    Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening setting.
    J Pathol. 2024 Mar 29. doi: 10.1002/path.6276.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share